查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1485298

细胞计数市场规模- 按产品类型（仪器[血球计数器、自动细胞计数器、血液分析仪]、耗材和试剂）、应用（全血计数、基于细胞的疗法、毒性）、最终用户和预测，2024 年- 2032 年

Cell Counting Market Size - By Product Type (Instruments [Hemocytometers, Automated Cell Counters, Hematology Analyzers], Consumable & Reagents), Application (Complete Blood Count, Cell-based Therapies, Toxicity), End-user & Forecast, 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在该领域技术和研究不断进步的推动下，2024 年至 2032 年间，全球细胞计数市场规模的复合年增长率将超过 8.8%。随着自动细胞计数、流式细胞仪和基于影像的细胞分析等不断创新，研究人员配备了更准确、更有效率和高通量的细胞群定量方法。例如，2024 年 1 月，研究人员推出了一种先进的人工智慧 (AI) 工具，旨在透过分析细胞分裂来评估癌症分级。这项尖端技术被称为 MitPro，可以准确计算有丝分裂数，这是各种癌症类型中癌症侵袭性的关键指标。

这些技术进步有助于简化实验室工作流程，同时能够在药物发现、癌症研究和再生医学等各种应用中精确分析细胞活力、增殖和凋亡。此外，对个人化医疗和精准治疗的日益关注进一步加大了对能够提供精确可靠结果的复杂细胞计数技术的需求。因此，随着细胞计数市场不断满足科学界不断增长的需求，它有望显着增长。

整个细胞计数产业根据产品类型、应用、最终用户和地区进行分类。

仪器部分将在2024年至2032年期间经历突破性的发展。从自动细胞计数器到流式细胞仪和基于影像的分析系统，市场提供了针对特定需求量身定制的各种仪器。随着个人化医疗的兴起和再生疗法的进步，对精确细胞计数仪器的需求不断升级，推动了细胞计数市场的创新和成长。

从2024 年到2032 年，基于细胞的治疗领域的细胞计数市场份额将实现显着的复合年增长率。剂量、品质控制和治疗监测功效。随着基于细胞的疗法在解决包括癌症和退化性疾病在内的各种疾病方面获得动力，对精确细胞计数技术的需求变得至关重要。这种需求推动了细胞计数市场的创新，推动了针对细胞疗法的具体要求量身定制的先进仪器和方法的开发，从而促进了其成功实施和广泛采用。

到 2032 年，欧洲细胞计数市场将累积可观的估值。从学术研究到临床诊断和药物开发，精确的细胞计数至关重要。此外，该地区对个人化医疗和再生疗法的重视进一步扩大了对精确细胞计数仪器和方法的需求。随着欧洲在医疗进步方面继续处于领先地位，在整个大陆医疗保健行业不断变化的需求的推动下，细胞计数市场经历了持续增长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性疾病和血液疾病的发生率增加
      • 政府对意识和批准的支持不断增加
      • 增加经费加速研发工作
      • 升级的细胞疗法研究
      • 细胞计数技术不断进步
    • 产业陷阱与挑战
      • 计数技术的局限性
      • 先进细胞计数系统的高成本
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品类型，2018 年 - 2032 年

  • 主要趋势
  • 仪器
    • 血球计数器
    • 自动细胞计数器
      • 基于萤光影像的细胞计数器
      • 流式细胞仪
      • 犁刀计数器
    • 血液分析仪
      • 全自动分析仪
      • 半自动分析仪
    • 图像细胞仪
    • 其他仪器
  • 耗材及试剂

第 6 章：市场估计与预测：按应用分类，2018 年 - 2032 年

  • 主要趋势
  • 全血球计数
  • 基于细胞的疗法
  • 生物加工
  • 毒性
  • 其他应用

第 7 章：市场估计与预测：按最终用户划分，2018 年 - 2032 年

  • 主要趋势
  • 医院
  • 诊断实验室
  • 研究机构
  • 製药和生物技术公司
  • 其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

  • 主要动向：按地区
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 中东和非洲其他地区

第 9 章：公司简介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biotek Instruments, Inc.
  • ChemoMetec A/S
  • DeNovix
  • Merck KGaA
  • NanoEnTek Inc
  • Olympus Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
简介目录
Product Code: 8496

Global Cell Counting Market Size will witness over 8.8% CAGR between 2024 and 2032, driven by continuous advancements in technology and research within the field. With ongoing innovations such as automated cell counting, flow cytometry, and image-based cell analysis, researchers are equipped with more accurate, efficient, and high-throughput methods for quantifying cellular populations. For instance, in January 2024, researchers unveiled an advanced artificial intelligence (AI) tool aimed at assessing cancer grading through the analysis of cell division. Known as MitPro, this cutting-edge technology accurately counts mitotic figures, which are crucial indicators of cancer aggressiveness, across various cancer types.

These technological advancements help streamline laboratory workflows while enabling precise analysis of cell viability, proliferation, and apoptosis across various applications, including drug discovery, cancer research, and regenerative medicine. Additionally, the growing focus on personalized medicine and precision therapeutics further amplifies the need for sophisticated cell counting technologies capable of delivering precise and reliable results. Consequently, the Cell Counting market is poised for significant growth as it continues to cater to the expanding demands of the scientific community.

The overall Cell Counting Industry is classified based on the product type, application, end-user, and region.

The instruments segment will undergo groundbreaking development from 2024 to 2032. These instruments play a critical role in quantifying cellular populations accurately and efficiently, facilitating various research and clinical applications. From automated cell counters to flow cytometers and image-based analysis systems, the market offers a diverse range of instruments tailored to specific needs. With the rise of personalized medicine and advancements in regenerative therapies, the demand for precise cell counting instruments continues to escalate, driving innovation and growth in the Cell Counting market.

The cell counting market share from the cell-based therapies segment will register a noteworthy CAGR from 2024 to 2032. These revolutionary treatments, ranging from stem cell therapies to immunotherapies, rely on accurate cell counting for dosage determination, quality control, and monitoring of treatment efficacy. As cell-based therapies gain momentum in addressing various diseases, including cancer and degenerative disorders, the need for precise cell counting technologies becomes paramount. This demand fuels innovation in the Cell Counting market, driving the development of advanced instruments and methodologies tailored to the specific requirements of cell-based therapies, thus facilitating their successful implementation and widespread adoption.

Europe cell counting market will amass a sizeable valuation by 2032. With a robust healthcare infrastructure and a focus on innovation, European researchers and clinicians increasingly rely on advanced cell counting technologies for various applications. From academic research to clinical diagnostics and pharmaceutical development, precise cell counting is essential. Moreover, the region's emphasis on personalized medicine and regenerative therapies further amplifies the demand for accurate cell counting instruments and methodologies. As Europe continues to lead in medical advancements, the Cell Counting market experiences sustained growth, driven by the evolving needs of the healthcare sector across the continent.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of chronic disease and blood disorders
      • 3.2.1.2 Growing government support for awareness and approval
      • 3.2.1.3 Increasing fundings accelerated R&D efforts
      • 3.2.1.4 Escalated cell-therapy-based research
      • 3.2.1.5 Growing advancement in cell counting technologies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Limitations of counting techniques
      • 3.2.2.2 High cost of advanced cell counting systems
  • 3.3 Regulatory landscape
  • 3.4 Porter's analysis
    • 3.4.1 Supplier power
    • 3.4.2 Buyer power
    • 3.4.3 Threat of new entrants
    • 3.4.4 Threat of substitutes
    • 3.4.5 Industry rivalry
  • 3.5 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Million)

  • 5.1 Key trends
  • 5.2 Instruments
    • 5.2.1 Hemocytometers
    • 5.2.2 Automated cell counters
      • 5.2.2.1 Fluorescence image-based cell counter
      • 5.2.2.2 Flow cytometer
      • 5.2.2.3 Coulter counter
    • 5.2.3 Hematology analyzers
      • 5.2.3.1 Fully-automated analyzers
      • 5.2.3.2 Semi-automated analyzers
    • 5.2.4 Image cytometry
    • 5.2.5 Other instruments
  • 5.3 Consumables & reagents

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Million)

  • 6.1 Key trends
  • 6.2 Complete blood count
  • 6.3 Cell-based therapies
  • 6.4 Bioprocessing
  • 6.5 Toxicity
  • 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Million)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Diagnostic laboratories
  • 7.4 Research institutes
  • 7.5 Pharmaceutical & biotechnology companies
  • 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Agilent Technologies, Inc.
  • 9.3 Beckman Coulter, Inc.
  • 9.4 Bio-Rad Laboratories, Inc.
  • 9.5 Biotek Instruments, Inc.
  • 9.6 ChemoMetec A/S
  • 9.7 DeNovix
  • 9.8 Merck KGaA
  • 9.9 NanoEnTek Inc
  • 9.10 Olympus Corporation
  • 9.11 Sysmex Corporation
  • 9.12 Thermo Fisher Scientific Inc.